Stockreport

Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1 [Yahoo! Finance]

Janus Henderson Group plc Ordinary Shares  (JHG) 
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am Check Earnings Report
US:NYSE Investor Relations: snl.com/irw/corporateprofile/4147331
PDF Jay Hagan joins as Chief Executive Officer leading a seasoned late-stage development team and will serve on the Board alongside Co-Founder and Chairman Keith Katkin O [Read more]